Nobuya Monden

Shikoku Cancer Center — Japan

Medicine · Health Sciences

18h-index3.9kcitations110works1.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Head and Neck Cancer Studies(59), Head and Neck Surgical Oncology(17), Lung Cancer Treatments and Mutations(14), Salivary Gland Tumors Diagnosis and Treatment(13), Cancer Diagnosis and Treatment(11)

Publications109 total

Risk factors for aspiration pneumonia related to postoperative chemoradiotherapy for high-risk head and neck cancer: A supplementary analysis of a phase II/III JCOG1008 trial.
Journal of Clinical Oncology·2025
Risk factors for distant metastasis in papillary thyroid carcinoma: Association with lateral lymph node metastasis
Auris Nasus Larynx·2025
Nationwide multi-centric prospective study for the identification of biomarkers to predict the treatment responses of nivolumab through comprehensive analyses of pretreatment plasma exosome mRNAs from head and neck cancer patients (BIONEXT study)
Frontiers in Immunology·2025Open Access
Effect of acute kidney injury and overall survival in patients with postoperative head and neck cancer who received chemoradiotherapy with cisplatin: A supplementary analysis of the phase <scp>II</scp>/<scp>III</scp> trial of <scp>JCOG1008</scp>
Cancer Medicine·2024· 5 citedOpen Access
851MO Final analysis of a phase II/III trial of post-operative chemoradiotherapy comparing 3-weekly cisplatin with weekly cisplatin in high-risk patients with squamous cell carcinoma of the head and neck (JCOG1008)
Annals of Oncology·2024· 1 citedOpen Access
Figures S1-S9, Tables S1-S5, Appendices 2-4 Data Supplementary1 from Apalutamide and Goserelin for Androgen Receptor–Positive Salivary Gland Carcinoma: A Phase II Nonrandomized Clinical Trial, YATAGARASU
2024Open Access
Figures S1-S9, Tables S1-S5, Appendices 2-4 Data Supplementary1 from Apalutamide and Goserelin for Androgen Receptor–Positive Salivary Gland Carcinoma: A Phase II Nonrandomized Clinical Trial, YATAGARASU
2024Open Access
Figures S1-S9, Tables S1-S5, Appendices 2-4 Data Supplementary1 from Apalutamide and Goserelin for Androgen Receptor–Positive Salivary Gland Carcinoma: A Phase II Nonrandomized Clinical Trial, YATAGARASU
2024Open Access
Data from Apalutamide and Goserelin for Androgen Receptor–Positive Salivary Gland Carcinoma: A Phase II Nonrandomized Clinical Trial, YATAGARASU
2024· 1 citedOpen Access
Figures S1-S9, Tables S1-S5, Appendices 2-4 Data Supplementary1 from Apalutamide and Goserelin for Androgen Receptor–Positive Salivary Gland Carcinoma: A Phase II Nonrandomized Clinical Trial, YATAGARASU
2024Open Access
Data from Apalutamide and Goserelin for Androgen Receptor–Positive Salivary Gland Carcinoma: A Phase II Nonrandomized Clinical Trial, YATAGARASU
2024Open Access
Incidence and risk factors associated with the development of hypothyroidism after postoperative chemoradiotherapy for head and neck cancer patients with high-risk features: Supplementary analysis of JCOG1008
Oral Oncology·2024· 2 cited
Primary malignant glomus tumors of the thyroid gland: A case report
Acta Oto-Laryngologica Case Reports·2024· 1 citedOpen Access
Apalutamide and Goserelin for Androgen Receptor–Positive Salivary Gland Carcinoma: A Phase II Nonrandomized Clinical Trial, YATAGARASU
Clinical Cancer Research·2024· 8 cited
Risk prediction model for cisplatin-induced acute kidney injury in patients with head and neck cancer receiving chemoradiotherapy: A re-analysis of a phase II/III JCOG1008 trial
Oral Oncology·2024· 6 cited
18: Secondary analysis of JCOG1008: Frequency and risk factors associated with the hypothyroidism
Radiotherapy and Oncology·2024
Comparison of the accuracy of clinical prediction of survival and palliative prognostic index for patients with head and neck squamous cell carcinoma in the end-of-life setting
Nippon Jibiinkoka Tokeibugeka Gakkai Kaiho(Tokyo)·2023Open Access
Prospective exploration of a prognostic biomarker of nivolumab for head and neck cancer patients (BIONEXT)
2023Open Access
A Case of Tracheobronchial Chondritis as an Immune-Related Adverse Event after Administration of Nivolumab in Treatment of Submandibular Carcinoma
Nihon Kikan Shokudoka Gakkai Kaiho·2023Open Access
Impact of acute kidney injury on overall survival in postoperative patients with head and neck cancer who received chemoradiotherapy with cisplatin: A supplementary analysis of a phase II/III trial of JCOG1008.
Journal of Clinical Oncology·2023· 3 cited
page 1 of 6Next →

Frequent Co-authors

Akihiro Homma(25), Ryuichi Hayashi(24), Shigemichi Iwae(21), Masato Fujii(18), Yasuhisa Hasegawa(17), Makoto Tahara(14), Nobuhiro Hanai(13), Kazuyoshi Kawabata(13), Ken‐ichi Nibu(12), Takahiro Asakage(12), Naomi Kiyota(12), Kazuto Matsuura(12), Takashi Fujii(11), Kenji Okami(10), Yusuke Onozawa(10), Yasushi Fujimoto(10), Takeshi Kodaira(9), Tetsuo Akimoto(8), Tsutomu Ueda(8), Shunji Takahashi(7)